EU Pharma Reform & Supply Chain Readiness

Pelargir helps pharmaceutical and biotech companies assess what the EU pharma reform means for their supply operations and prepare for the changes ahead.

We provide pragmatic advice and hands-on support, with a focus on distribution models, shortage-prevention readiness and partner responsibilities. Working closely with your organisation, we translate evolving requirements into clear priorities and practical implementation plans.

How We Can Support You

Supply Chain Readiness Assessment

Understand where changes may be needed across your supply operations. We review your current arrangements, identify gaps and dependencies, and develop a prioritised action plan tailored to your business.

Distribution Models & Partner Responsibilities

Assess how evolving requirements may affect your distribution model. We map product flows, ownership and invoicing arrangements, review the roles of internal teams and external partners, and help define a practical way forward.

Shortage-Prevention Readiness

Strengthen the processes that support reliable patient supply. We help assess supply vulnerabilities, improve visibility and establish clear responsibilities, escalation triggers and mitigation actions.

Implementation Support

Turn recommendations into operational change. We support planning, cross-functional coordination and implementation across processes, partners and systems—with a clear focus on maintaining continuity of supply.

A Practical Approach

Not every company needs to redesign its supply chain. Our starting point is your existing model, your priorities and the changes relevant to your business.

Support can range from a focused assessment to hands-on implementation. Where required, we work with regulatory and legal specialists to connect their advice with practical supply chain decisions.